CVHFR Risk Calculator

Sex

Ethnicity

Age

BMI

Waist-to-Height Ratio

Diabetes

HbA1c (%)

LDL Cholesterol (mg/dL)

Systolic Blood Pressure (mmHg)

Coronary Artery Calcium Score

Urine Microalbumin-to-Creatinine Ratio (mg/g)

FIB-4 Score

hs-CRP (mg/L)

Smoking Status

Prior CV Event (e.g., MI, Stroke, PAD)

Obstructive Sleep Apnea

Family History of CV Disease

Genetic Risk Score (if known)

Lipoprotein(a) (mg/dL)

ApoB (mg/dL)

NT-proBNP (pg/mL)

Ejection Fraction (%)

E/E' Ratio

eGFR (mL/min/1.73m²)

On Statins

Hypertension or on Treatment

On GLP-1RA (e.g., liraglutide, semaglutide)

On SGLT2i (e.g., empagliflozin, dapagliflozin):

On ARB (e.g., losartan, telmisartan):

On ARNI (e.g., sacubitril/valsartan):

On MRA (e.g., spironolactone, finerenone):

On Thiazolidinedione (e.g., pioglitazone):

Maximum Possible Score: ~80 (varies with NT-proBNP, EF, etc.)

Risk Categories: 0–10 (Low), 11–22 (Moderate), 23–35 (High), 36+ (Very High)

Odds Ratios (OR) use literature effects where applicable (e.g., SGLT2i, GLP-1RA, statins); CIs assume n=5000 per group.

Disclaimer: This tool is for educational purposes only and should not be used for clinical decision-making without professional medical advice.

References: